文献速递生殖医学

子宫内膜异位症女性接受辅助生殖技术治疗的累积活产率

Cumulative live birth rates in women with endometriosis undergoing ART treatment.
PubMed 文献 · Hum Reprod · 2025-01-01

这项回顾性队列研究纳入2014至2019年在澳大利亚和新西兰启动自体辅助生殖技术的79 318名女性,随访至2021年或首次活产。单纯子宫内膜异位症组第6个完整周期的累积活产率为64%至83%,高于无子宫内膜异位症组的57.3%至76.5%和子宫内膜异位症合并其他不孕因素组的54.3%至68.7%。与无子宫内膜异位症女性相比,单纯子宫内膜异位症组活产率升高6%(RR 1.06,95%CI 1.04-1.08),子宫内膜异位症合并其他不孕因素组降低5%(RR 0.95,95%CI 0.93-0.97)。

要点

  • 单纯子宫内膜异位症组第6周期累积活产率64%至83%,高于无子宫内膜异位症组57.3%至76.5%。
  • 合并其他不孕因素的子宫内膜异位症组第6周期累积活产率54.3%至68.7%,低于无子宫内膜异位症组。
  • 合并其他不孕因素的子宫内膜异位症组流产风险较单纯子宫内膜异位症组高46%(RR 1.46,95%CI 1.35-1.59)。

核心结论

  • 单纯子宫内膜异位症作为唯一不孕原因的女性,其累积活产率高于子宫内膜异位症合并其他不孕因素者或其他非子宫内膜异位症原因不孕者。
  • 单纯子宫内膜异位症组较高的累积活产率提示孤立性子宫内膜异位症不负面影响辅助生殖技术结局,合并其他不孕因素者需要个体化管理。

研究设计与样本

  • 回顾性队列研究,纳入2014至2019年在澳大利亚和新西兰启动自体辅助生殖技术的79 318名女性,随访至2021年或首次活产。
  • 按不孕诊断分为三组:单纯子宫内膜异位症组(n=4311)、子宫内膜异位症合并其他不孕因素组(n=6312)、其他不孕原因组(n=68 695,无子宫内膜异位症)。
  • 基于对中断治疗女性活产机会的假设,计算保守和最优累积活产率。

主要发现

  • 子宫内膜异位症作为唯一不孕原因者占5%,子宫内膜异位症合并其他诊断者占8%,其他不孕原因者占63%,不明原因不孕者占24%。
  • 第6个完整周期累积活产率:单纯子宫内膜异位症组64%至83%,子宫内膜异位症合并其他不孕因素组54.3%至68.7%,无子宫内膜异位症组57.3%至76.5%(取决于对中断治疗者的假设)。
  • 与无子宫内膜异位症女性相比,单纯子宫内膜异位症组活产率升高6%(RR 1.06,95%CI 1.04-1.08),子宫内膜异位症合并其他不孕因素组降低5%(RR 0.95,95%CI 0.93-0.97)。
  • 与单纯子宫内膜异位症组相比,子宫内膜异位症合并其他不孕因素组流产风险高46%(RR 1.46,95%CI 1.35-1.59)。

临床怎么用

  • 这些发现为向子宫内膜异位症女性咨询辅助生殖技术成功率提供了关键数据。
  • 单纯子宫内膜异位症组较高的累积活产率提示孤立性子宫内膜异位症不负面影响辅助生殖技术结局。
  • 作者指出,合并其他不孕因素的子宫内膜异位症女性需要个体化管理。

局限性

  • 研究未评估子宫内膜异位症的严重程度或表型,这些可能影响辅助生殖技术结局。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

STUDY QUESTION: How do cumulative live birth rates (CLBRs) in women with endometriosis compare to those with other infertility diagnoses undergoing ART? SUMMARY ANSWER: Women with endometriosis as the sole cause of infertility achieved higher CLBRs compared to those with additional infertility diagnoses (endometriosis-plus) or other non-endometriosis causes of infertility. WHAT IS KNOWN ALREADY: Endometriosis affects approximately 10% of women of reproductive age and is a major cause of infertility, with many women resorting to ART treatments in the hope of achieving a pregnancy. However, the comparative success rates of ART for these women, compared to those with other causes of infertility is not well understood. STUDY DESIGN, SIZE, DURATION: This retrospective cohort study included 79 318 women who initiated autologous ART between 2014 and 2019 in Australia and New Zealand, with follow-up through 2021 or the first live birth. PARTICIPANTS/MATERIALS, SETTING, METHODS: Participants were categorized into three groups based on infertility diagnosis: endometriosis-only (n = 4311), endometriosis-plus (n = 6312; endometriosis with other infertility factors) and other-infertility (n = 68 695; no endometriosis). Conservative and optimal CLBRs were calculated based on assumptions made about the chance of live birth for women who discontinued treatment. MAIN RESULTS AND THE ROLE OF CHANCE: Endometriosis was reported as the sole cause of infertility in 5% of women (endometriosis-only), while 8% had endometriosis with other diagnoses (endometriosis-plus). The remaining women had either other causes of infertility (63%) or unexplained infertility (24%). Depending on assumptions made regarding patients who discontinued treatment, the CLBR by the sixth complete cycle for women diagnosed with endometriosis-only ranged from 64% to 83%; for women with an endometriosis-plus diagnoses, the CLBR ranged from 54.3% to 68.7%; and for women without endometriosis, the CLBR ranged from 57.3% to 76.5%. Compared to women without endometriosis, the live birth rate was 6% higher in endometriosis-only group (RR: 1.06; 95% CI: 1.04-1.08) and 5% lower in endometriosis-plus group (RR: 0.95; 95% CI: 0.93-0.97). Compared to the endometriosis-only group, pregnancy loss was 46% higher (RR: 1.46; 95% CI: 1.35-1.59) in endometriosis-plus group. LIMITATIONS, REASONS FOR CAUTION: The study did not assess endometriosis severity or phenotype, which may influence ART outcomes. WIDER IMPLICATIONS OF THE FINDINGS: These findings provide critical data for counselling women with endometriosis regarding ART success. The higher CLBR in the endometriosis-only group suggests that isolated endometriosis does not negatively impact ART outcomes and highlights the need for tailored management in women with additional infertility factors. STUDY FUNDING/COMPETING INTEREST(S): This study is funded through the Medical Research Future Fund (MRFF) Research Data Infrastructure grant (MRFRFD000065). The sponsors had no role in the design and conduct of the study; data collection, management, analysis and interpretation; manuscript preparation, review, or approval; or the decision to submit for publication. FSANZ contracts National Perinatal Epidemiology and Statistics Unit (NPESU) of the University of New South Wales (UNSW) to prepare annual reports and benchmarking reports from the Australian and New Zealand Assisted Reproductive Technology Database (ANZARD): one of those datasets is used in this study. R.C.P. is a Research Fellow of the NPESU, UNSW. G.M.C. is the Director of the NPESU, UNSW. J.A. reports support from the Medical Research Future Fund and the Australian Government Department of Health and Aged Care, consulting fees from Hologic and Gedeon Richter, honoraria from Hologic, and advisory board participation with Gedeon Richter. G.D.M. reports funding from the NHMRC and the Australian Government Department of Health and Aged Care and is lead editor of a book published by Oxford University Press. C.N. reports institutional funding, an unpaid leadership role with ACTA and is a former employee of CSL Vifor. R.D., A.H., and I.R. declare no conflicts of interest. TRIAL REGISTRATION NUMBER: N/A.

来源:Hum Reprod,查看原文。版权归原作者所有。

引用

  1. Paul RC, Deans R, Henry A, et al. Cumulative live birth rates in women with endometriosis undergoing ART treatment. Hum Reprod. 2025. PMID: 41052783. doi:10.1093/humrep/deaf191

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。